TSH-displacing activity versus TSH-binding inhibiting activity of immunoglobulins from patients with Graves’ disease
- 1 October 1983
- journal article
- research article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 6 (5) , 375-378
- https://doi.org/10.1007/bf03347619
Abstract
Inhibition of binding of TSH to thyroid plasma membranes by immunoglobulins G (IgG) from patients with Graves’ disease has been interpreted as evidence of an interaction with the TSH receptor, but other explanations may account for this phenomenon. Displacement of receptor-bound TSH might be a more direct index of such an interaction. The aim of the present study was to assess TSH-displacing activity (TDA) of Graves’ IgG by a newly developed assay and compare TDA to TSH-binding inhibiting activity (TBIA) and thyroid-stimulating antibody (TSAb) activity. TDA was assessed by preincubating 125I-TSH with thyroid plasma membranes and by measuring residual bound 125I-TSH after addition of IgG. TBIA was evaluated by determining binding of 125I-TSH to thyroid plasma membranes preincubated with IgG. Results were expressed as % TSH-displacing or binding inhibition activities of test IgG with respect to normal control IgG. The percent of TDA positive Graves’ IgG preparations (72.7%) was greater than that of TBIA positive (48.5%). There was no correlation between TDA and TBIA results, since 11 Graves’ IgG preparations were TDA positive but TBIA negative, and 6 were TDA negative but TBIA positive. Hashimoto’s or idiopatic myxedema IgG preparations were positive in 2/7 in the TDA and in 1/7 in the TBIA assays, respectively. Neither TDA nor TBIA correlated with TSAb determined by cAMP accumulation in thyroid plasma membrane. The TDA assay developed in this study appeared to be more sensitive than the more widely used TBIA assay. No correlation was found between the two assays, indicating that inhibition of TSH binding and displacement of bound TSH are not equivalent and may be due to different phenomena. TDA as well as TBIA were also unrelated to TSAb activity, suggesting that interaction with the TSH receptor does not necessarily imply stimulation of thyroid function.This publication has 16 references indexed in Scilit:
- Solubilization, Purification, and Partial Characterization of Thyrotropin Receptor from Bovine and Human Thyroid Glands*Endocrinology, 1982
- COMPARISON BETWEEN THYROID STIMULATING AND TSH-BINDING INHIBITING IMMUNOGLOBULINS OF GRAVES' DISEASEClinical Endocrinology, 1981
- Monoclonal antibodies to the thyrotropin receptor: implications for receptor structure and the action of autoantibodies in Graves disease.Proceedings of the National Academy of Sciences, 1981
- Correlation between Thyroid Stimulators and 3,5,3′-Triiodothyronine Suppressibility in Patients during Treatment for Hyperthyroidism with Thionamide Drugs:Comparison of Assays by Thyroid-Stimulating and Thyrotropin-Displacing Activities*Journal of Clinical Endocrinology & Metabolism, 1979
- Correlation between Thyrotropin-Displacing Activity and Human Thyroid-Stimulating Activity by Immunoglobulins from Patients with Graves' Disease and Other Thyroid Disorders*Journal of Clinical Endocrinology & Metabolism, 1979
- Contribution of negative cooperativity to the thyrotropin-receptor interaction in normal human thyroid: kinetic evaluation.Proceedings of the National Academy of Sciences, 1979
- Detection and Properties of TSH-Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Hashimoto’s Thyroiditis*Journal of Clinical Endocrinology & Metabolism, 1978
- Humoral immunity in Graves' diseaseClinics in Endocrinology and Metabolism, 1978
- RELATION OF THYROID-STIMULATING IMMUNOGLOBULINS TO THYROID FUNCTION AND EFFECTS OF SURGERY, RADIOIODINE, AND ANTITHYROID DRUGSThe Lancet, 1975
- THYROID STIMULATORS IN HEALTH AND DISEASE*Clinical Endocrinology, 1975